BASELINE CHARACTERISTICS IN THE "CARDINAL" TRIAL: A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME

被引：0

作者：

Knebelmann, Bertrand ^{[1
]}

Appel, Gerald ^{[2
]}

Block, Geoffrey ^{[3
]}

Chin, Melanie ^{[3
]}

Goldsberry, Angie ^{[3
]}

Inker, Lesley ^{[4
]}

Kashtan, Clifford ^{[5
]}

Meyer, Colin ^{[3
]}

Nozu, Kandai ^{[6
]}

Pergola, Pablo ^{[7
]}

Rastogi, Anjay ^{[8
]}

Rheault, Michelle ^{[5
]}

Silva, Arnold ^{[9
]}

Sprague, Stuart ^{[10
]}

Warady, Bradley ^{[11
]}

Gross, Oliver ^{[12
]}

机构：

[1] Hop Necker Enfants Malad, Paris, France

[2] Columbia Univ Coll Phys & Surg, 630 W 168th St, New York, NY 10032 USA

[3] Reata Pharmaceut Inc, Irving, TX USA

[4] Tufts Univ, Boston, MA 02111 USA

[5] Univ Minnesota, Minneapolis, MN USA

[6] Kobe Univ, Grad Sch Med, Kobe, Hyogo, Japan

[7] Renal Associates, San Antonio, TX USA

[8] Univ Calif Los Angeles, Los Angeles, CA USA

[9] Boise Kidney & Hypertens Inst, Meridian, ID USA

[10] NorthShore Univ HealthSyst, Evanston, IL USA

[11] Univ Missour Kansas City, Sch Med, Kansas City, MO USA

[12] Univ Gottingen, Gottingen, Germany

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2019年 / 34卷

关键词：

D O I：

暂无

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

FP179

引用

页码：104 / 104

页数：1

共 50 条

[41] Impact of baseline characteristics on the efficacy of ixekizumab in patients with moderate to severe psoriasis in a phase 2 study
Papp, Kim
Zhu, Baojin
Leonardi, Craig
Cameron, Gregory
Erickson, Janelle
Heffernan, Michael
Banerjee, Subhashis
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB171 - AB171
[42] The efficacy and safety of setmelanotide in individuals with Bardet-Biedl syndrome or Alstrom syndrome: Phase 3 trial design
Haws, Robert M.
Gordon, Gregory
Han, Joan C.
Yanovski, Jack A.
Yuan, Guojun
Stewart, Murray W.
CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2021, 22
[43] Impact of Baseline Corticosteroid Use on the Efficacy and Safety of Upadacitinib in Patients with Ulcerative Colitis: A Post Hoc Analysis of the Phase 3 Clinical Trial Programme
Raine, Tim
Ishiguro, Yoh
Rubin, David T.
Finney-Hayward, Tricia
Vladea, Ramona
Liu, John
Phillips, Charles
Cheng, Erica
Targownik, Laura
Loftus Jr, Edward, V
JOURNAL OF CROHNS & COLITIS, 2024, 18 (05): : 695 - 707
[44] Randomized controlled trial on the efficacy and safety of atorvastatin in patients with type 2 diabetes on hemodialysis (4D study):: Demographic and baseline characteristics
Wanner, C
Krane, V
März, W
Olschewski, M
Asmus, HG
Krämer, W
Kühn, KW
Kütemeyer, H
Mann, JFE
Ruf, G
Ritz, E
KIDNEY & BLOOD PRESSURE RESEARCH, 2004, 27 (04): : 259 - 266
[45] An Open-Label Phase 3 TRial to EValuate the Safety of Eptinezumab Administered IntravenousLy in Patients with Chronic Migraine (PREVAIL): Demographics and Baseline Characteristics
Song, Y.
Biondi, D.
Cady, R.
Hirman, J.
Schaeffler, B.
HEADACHE, 2019, 59 : 121 - 122
[46] EFFICACY AND SAFETY OF LENABASUM IN THE PHASE 3 DETERMINE TRIAL IN DERMATOMYOSITIS
Werth, V.
White, B.
Dgetluck, N.
Hally, K.
Constantine, S.
Aggarwal, R.
Fiorentino, D.
Lundberg, I. E.
Oddis, C. V.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 106 - 107
[47] Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial
Harrington, Josephine
Mentz, Robert J.
Rockhold, Frank W.
Garg, Jyotsna
Butler, Javed
Pasquale, Carmine G. De
Ezekowitz, Justin A.
Lewis, Gregory D.
O'Meara, Eileen
Ponikowski, Piotr
Troughton, Richard W.
Wong, Yee Weng
Adamczyk, Robert
Blackman, Nicole
Hernandez, Adrian F.
AMERICAN HEART JOURNAL, 2023, 266 : 25 - 31
[48] A PHASE 3 TRIAL OF THE EFFICACY AND SAFETY OF ORAL RECOMBINANT CALCITONIN: THE ORACAL TRIAL
Binkley, Neil
Bologonese, Michael
Sidorowicz-Bialynicka, Anna
Vally, Tasneem
Buben, Christine
Gilligan, James
Krause, David
OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S78 - S78
[49] Efficacy and safety of pegcetacoplan in patients with geographic atrophy from phase 3 OAKS and DERBY trials and efficacy from Phase 3 GALE Trial
Wong, James
Li, Chao
Burch, Mark
Ribeiro, Ramiro
CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 51 (09): : 932 - 932
[50] Efficacy and Safety of Tofacitinib in Patients with Ankylosing Spondylitis by Baseline BMI: A Post Hoc Analysis of Phase 2 and Phase 3 Trials
Norton, Hillary
Sliwinska-Stanczyk, Paula
Hala, Tomas
Elzorkany, Bassel
Stockert, Lori
Shi, Harry
Wang, Cunshan
Paulissen, Jerome
Ritchlin, Christopher
ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 800 - 803

← 1 2 3 4 5 →